Почетна › Рак (сите типови) › Масачусетс › Boston
Клинички испитувања за Рак (сите типови) во Boston, MA
85 студии за Рак (сите типови) бараат учесници на локации во и околу Boston (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
PediRISE Feasibility
Се регрутира
- Boston Children's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Distance-Based Exercise to Preserve Function and Prevent Disability
Се регрутира
- Dana-Farber Cancer Institute, Boston
A Study of ASP3082 in Adults With Advanced Solid Tumors
Се регрутираФаза 1
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Се регрутираФаза 1
- Beth Israel Deaconess Medical Center - Research, Boston
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Се регрутираФаза 1
- Massachusetts General Hospital, Boston
A Study of PHN-012 in Patients With Advanced Solid Tumors
Се регрутираФаза 1
- PHN-012-001 Site, Boston
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Се регрутираНабљудувачка студија
- Mass General Brigham, Boston
- Brigham and Women's Hospital, Boston
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Се регрутираФаза 3
- Investigative Site, Boston
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Се регрутираФаза 1/2
- Dana Farber Cancer Center ( Site 4013), Boston
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Се регрутираФаза 3
- Dana Farber/Harvard Cancer Center, Boston
Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Се регрутира
- Massachusetts General Hospital, Boston
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Се регрутираФаза 3
- Dana-Farber Cancer Institute /ID# 279690, Boston
Pan Tumor Rollover Study
Се регрутираФаза 2
- Dana_Farber Cancer Institute (DFCI), Boston
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
Се регрутираФаза 3
- Beth Israel Deaconess Medical Center ( Site 0107), Boston
- Dana-Farber Cancer Institute ( Site 0105), Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Се регрутираФаза 1/2
- Dana Farber Cancer Institute, Boston
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Се регрутираФаза 2/3
- Massachusetts General Hospital / Dana-Farber Cancer Institute, Boston
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Се регрутираФаза 1/2
- Dana-Farber Cancer Institute ( Site 3013), Boston
ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs
Се регрутира
- Dana-Farber Cancer Institute, Boston
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
Се регрутира
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Statins to Prevent Cancer Associated Blood Clots
Се регрутираФаза 4
- Beth Isreal Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Се регрутираФаза 2
- Dana-Farber Cancer Institute, Boston
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Се регрутираФаза 2
- Dana Farber Cancer Institute, Boston
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Се регрутираФаза 1/2
- Dana-Farber Cancer Institute /ID# 271846, Boston
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Се регрутираФаза 1/2
- Research Site, Boston
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Се регрутираФаза 1
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Се регрутираФаза 1/2
- Dana-Farber Cancer Institute, Boston
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Се регрутираФаза 3
- Boston Medical Center, Boston
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Се регрутираНабљудувачка студија
- Dana Farber Cancer Institute, Boston
Prostate Active Surveillance Study
Се регрутираНабљудувачка студија
- Beth Israel Deaconess Medical Center/Harvard Medical School, Boston
Lurbinectedin in FET-Fused Tumors
Се регрутираФаза 1/2
- Dana-Farber Cancer Institute, Boston
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Massachusetts General Hospital (MG), Boston
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Се регрутираФаза 1
- Massachusetts General Hospital, Boston
BRIDGE-SIC Efficacy Trial
Се регрутира
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Project: Every Child for Younger Patients With Cancer
Се регрутираНабљудувачка студија
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Се регрутираФаза 3
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Boston Medical Center, Boston
- и уште 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Се регрутираФаза 1/2
- Massachusetts General Hospital, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
Се регрутираФаза 1
- Beth Israel Deaconess Medical Center, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- Massachusetts General Hospital Cancer Center, Boston
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Се регрутираФаза 1
- Dana-Farber Cancer Institute, Boston
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Се регрутираФаза 2
- Dana-Farber Cancer Institute, Boston
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
Се регрутираФаза 1Добредојдени се здрави волонтери
- Boston Medical Center, Boston
- Massachusetts General Hospital (MGH), Charlestown · на 1 милји
Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
Се регрутираФаза 1
- Brigham and Women's Hospital, Boston
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Се регрутираФаза 2
- Massachusetts General Hospital /ID# 273608, Boston
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Се регрутираФаза 1
- Dana-Farber Cancer Institute, Boston
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
The STOP-MED CTRCD Trial
Се регрутираФаза 4
- Brigham and Women's Hospital, Boston
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Се регрутираФаза 1/2
- Dana Farber Cancer Institute, Boston
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Се регрутираФаза 1
- GSK Investigational Site, Boston
- GSK Investigational Site, Boston
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Се регрутираФаза 1/2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Childhood Cancer Survivor Study
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Dana-Farber Cancer Institute, Boston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Се регрутира
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Се регрутираФаза 1
- Research Site, Boston
- Research Site, Boston
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Се регрутираФаза 1
- Beth Israel Deaconess Medical Center /ID# 252009, Boston
- Dana-Farber Cancer Institute /ID# 249642, Boston
Multisite Implementation of COMPRENDO
Се регрутираДобредојдени се здрави волонтери
- Dana Farber Cancer Institute/Boston Children's Hospital, Boston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Се регрутираФаза 1
- Mass General Brigham Cancer Institute, Boston
- Dana Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Се регрутираФаза 1/2
- Massachusetts General Hospital,, Boston
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Се регрутираФаза 1
- GSK Investigational Site, Boston
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Се регрутира
- Dana Farber Cancer Institute, Boston
On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety
Се регрутираНаведува исплата за учесниците
- Dana Farber Cancer Institute, Boston
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Се регрутираФаза 1/2
- Massachusetts General Hospital, Boston
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
Се регрутираФаза 2
- Dana Farber Cancer Institute, Boston
Intraoperative Tumor Margin Identification With ICG Dye Imaging
Се регрутираФаза 2
- Massachusetts General Hospital, Boston
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- Massachusetts General Hospital, Boston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Се регрутираФаза 1/2
- Dana Farber Cancer Institute, Boston
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Се регрутираФаза 2
- Massachusetts Eye and Ear, Boston
Supportive Care Intervention for Outpatient Stem Cell Transplant Patients
Се регрутира
- Dana-Farber Cancer Institute, Boston
Positron Emission Tomography (PET) Imaging of Thrombosis
Се регрутираФаза 1Добредојдени се здрави волонтери
- Massachusetts General Hospital, Boston
Primary Tumor Research and Outcomes Network
Се регрутираНабљудувачка студија
- Massachusetts General Hospital, Boston
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
Се регрутираФаза 1/2
- Dana Farber Cancer Institute, Boston
- Beth Israel Deaconess Medical Center, Boston
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Се регрутира
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Се регрутираФаза 2
- Dana-Farber Cancer Institute /ID# 230061, Boston
A Study of YL242 in Subjects With Advanced Solid Tumors
Се регрутираФаза 1/2
- US-204, Boston
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
Се регрутираДобредојдени се здрави волонтери
- Codman Square Health Center, Boston
- East Boston Neighborhood Health Center, East Boston · на 2 милји
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Се регрутираНабљудувачка студија
- Boston Children's Hospital, Boston
Childhood Cancer Predisposition Study (CCPS)
Се регрутираНабљудувачка студија
- Dana Farber Cancer Institute, Boston
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Се регрутира
- Massachusetts General Hospital Cancer Center, Boston
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Се регрутираНабљудувачка студија
- Massachusetts General Hospital, Boston
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
Се регрутира
- Harvard School of Medicine/Massachusetts General Hospital (MGH), Boston
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Се регрутираФаза 1/2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs
Се регрутираДобредојдени се здрави волонтери
- Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Се регрутираФаза 1/2
- Massachusetts General Hospital, Boston
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Се регрутираФаза 1/2
- Massachusetts General Hospital, Boston
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Се регрутираФаза 3
- Massachusetts General Hospital, Boston
Испитувања за Рак (сите типови) во други градови
- Houston, TX121 студија
- New York City, NY109 студии
- Los Angeles, CA74 студии
- Nashville, TN65 студии
- Philadelphia, PA59 студии
- Washington, DC58 студии
- Durham, NC58 студии
- Chicago, IL51 студија
- Atlanta, GA49 студии
- Seattle, WA49 студии
- Arlington, VA48 студии
- St. Louis, MO46 студии
Други студии во Boston
- Рак на дојка112 студии
- Рак на бели дробови со не-мали клетки90 студии
- Метастатски карцином63 студии
- Колоректален карцином63 студии
- Рак на бели дробови62 студии
- Карцином на јајниците61 студија
- Рак на простата59 студии
- Депресија52 студии
- Рак на ендометриумот50 студии
- Срцева слабост44 студии
- Акутна миелоидна леукемија44 студии
- Карцином на панкреасот43 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.